Primary Site >> Colorectal Cancer

Gene >> RASSF10

Journal: Oncotarget. 2015 Feb 28;6(6):4202-13.
Title: RASSF10 suppresses colorectal cancer growth by activating P53 signaling and sensitizes colorectal cancer cell to docetaxel.
Author: Guo, Jing|Yang, Yage|Yang, Yunsheng|Linghu, Enqiang|Zhan, Qimin|Brock, Malcolm V|Herman, James G|Zhang, Bingyong|Guo, Mingzhou
PMID: 25638156
Journal: Genes Cancer. 2015 May;6(5-6):231-40.
Title: RASSF10 suppresses hepatocellular carcinoma growth by activating P53 signaling and methylation of RASSF10 is a docetaxel resistant marker.
Author: Jin, Yongshuai|Cao, Baoping|Zhang, Meiying|Zhan, Qimin|Herman, James G|Yu, Miao|Guo, Mingzhou
PMID: 26124922
Journal: Hum Pathol. 2017 Apr;62:108-114.
Title: Low expression of RASSF10 is associated with poor survival in patients with colorectal cancer.
Author: Wang, Fei|Li, Peng|Feng, Ying|Hu, Yi-Lin|Liu, Yi-Fei|Guo, Yi-Bing|Jiang, Xin-Lin|Mao, Qin-Sheng|Xue, Wan-Jiang
PMID: 28041974
Journal: Medicine (Baltimore). 2017 Oct;96(42):e7011.
Title: Decreased expression of RASSF10 correlates with poor prognosis in patients with colorectal cancer.
Author: Ma, Junxun|Zhang, Sujie|Hu, Yi|Li, Xiaoyan|Yuan, Fang|Sun, Danyang|Wang, Lijie|Zhang, Fan|Chen, Guangying|Cui, Pengfei
PMID: 29049167